MOU with Craft Health
October 20 2023
Revolutionising Drug Delivery in Europe with 3D Printing Technology
In a move poised to reshape pharmaceutical manufacturing, GMP Manufacturing and Craft Health, a Singaporean pioneer in 3D-printed pharmaceuticals, announced a groundbreaking partnership at the 2023 Industrial Transformation ASIA-PACIFIC (ITAP) conference.
This collaboration brings together GMP's extensive manufacturing experience with Craft Health's cutting-edge 3D printing platform offering customised drug delivery solutions across pharmaceuticals and nutraceuticals throughout the UK and European markets.
A Future of Personalised Medicine
The traditional, one-size-fits-all approach to medication is rapidly evolving. This partnership signifies a significant leap towards a future of personalised medicine, where treatments are tailored to individual needs for improved patient experience and adherence.
Craft Health's 3D printing platform offers a unique and versatile solution. This integrated platform combines hardware, software, and formulation expertise, enabling:
- Flexible small batch production: This allows for pilot studies, personalised treatment plans, and catering to individual patient needs.
- Customisation across multiple parameters: Active ingredients, controlled release profiles, geometry, color, and even taste can all be customised, ensuring patients receive medication in a format that best suits them.
- Faster development and testing: Agile prototyping allows for quicker advancements in new drug delivery solutions.
- Consistent quality and efficiency: The automated 3D printing process ensures adherence to Good Manufacturing Practice (GMP) standards and streamlines production.
- Heat and UV-free printing: This protects the integrity of sensitive medications.
A Paradigm Shift in Pharmaceutical Manufacturing
This partnership between GMP Manufacturing and Craft Health represents a significant step forward in personalised medicine. By leveraging 3D printing technology, we aim to transform the way pharmaceuticals are manufactured and delivered in Europe, ultimately leading to improved patient outcomes and a brighter future for healthcare.
